LLY ▼ -0.5% - Eli Lilly and Company
$LLY ELI LILY: TALTZ AND ZEPBOUND TOGETHER SHOW BROADER BIOMARKER CHANGES VS. TALTZ ALONE || NEW PHASE 3B DATA ON LILLY'S TALTZ AND ZEPBOUND ADVANCE UNDERSTANDING OF THE INTERCONNECTED IMMUNE AND METABOLIC BIOLOGY IN ADULTS WITH PSORIASIS AND OBESITY
09-OCT-2026 06:49 AM ET
Share this post
More filings for $LLY
LLY ▲ +4.3% - Eli Lilly and CompanyOct 29, 2026LLY ▲ +3.9% - Eli Lilly and CompanyOct 29, 2026LLY ▲ +3.9% - Eli Lilly and CompanyOct 29, 2026LLY ▲ +3.9% - Eli Lilly and CompanyOct 29, 2026LLY ▼ -0.7% - Eli Lilly and CompanyOct 28, 2026LLY ▲ +0.1% - Eli Lilly and CompanyOct 27, 2026
View full $LLY filing history →💬 Comments
Loading comments…
Leave a comment
